Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A
Status:
Completed
Trial end date:
2018-03-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain additional data on the safety and efficacy of Wilate
in PTPs with hemophilia A with at least 150 previous exposure days (EDs) to a FVIII
concentrate who undergo prophylactic treatment with Wilate for 6 months and at least 50 EDs,
thus supplementing the existing database to obtain approval of Wilate for the indication
hemophilia A in the USA.